IRIS
1.5 Abstract in rivista
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 19.481
NA - Nord America 10.929
EU - Europa 4.213
SA - Sud America 1.380
AF - Africa 192
Continente sconosciuto - Info sul continente non disponibili 114
OC - Oceania 94
Totale 36.403
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 14.006
US - Stati Uniti d'America 10.435
CN - Cina 2.294
IT - Italia 2.143
HK - Hong Kong 1.310
BR - Brasile 978
GB - Regno Unito 646
VN - Vietnam 553
FR - Francia 495
BD - Bangladesh 331
IN - India 308
DE - Germania 267
CA - Canada 255
AR - Argentina 145
NL - Olanda 112
ID - Indonesia 108
TR - Turchia 98
MX - Messico 93
EC - Ecuador 76
CO - Colombia 74
AU - Australia 66
CZ - Repubblica Ceca 57
EE - Estonia 57
FI - Finlandia 57
JP - Giappone 54
PK - Pakistan 53
UA - Ucraina 51
PL - Polonia 45
SA - Arabia Saudita 45
ES - Italia 44
ZA - Sudafrica 43
MY - Malesia 41
PH - Filippine 40
IQ - Iraq 39
EG - Egitto 32
CL - Cile 31
JM - Giamaica 29
RU - Federazione Russa 29
VE - Venezuela 27
PY - Paraguay 25
MD - Moldavia 23
NZ - Nuova Zelanda 22
AE - Emirati Arabi Uniti 21
IE - Irlanda 21
SE - Svezia 20
TW - Taiwan 20
AT - Austria 19
CR - Costa Rica 17
NP - Nepal 17
ET - Etiopia 16
MA - Marocco 16
TN - Tunisia 16
HN - Honduras 15
DO - Repubblica Dominicana 14
TH - Thailandia 14
CH - Svizzera 13
AZ - Azerbaigian 12
GT - Guatemala 12
KZ - Kazakistan 12
LT - Lituania 12
UZ - Uzbekistan 12
IR - Iran 11
UY - Uruguay 11
KE - Kenya 10
KW - Kuwait 10
NI - Nicaragua 10
TT - Trinidad e Tobago 10
DK - Danimarca 9
HU - Ungheria 9
KR - Corea 9
OM - Oman 9
PR - Porto Rico 9
PT - Portogallo 9
BE - Belgio 8
GH - Ghana 8
NO - Norvegia 8
RO - Romania 8
SV - El Salvador 8
AL - Albania 7
DZ - Algeria 7
IL - Israele 7
NG - Nigeria 7
PE - Perù 7
GP - Guadalupe 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
BO - Bolivia 5
CW - ???statistics.table.value.countryCode.CW??? 5
GR - Grecia 5
JO - Giordania 5
KG - Kirghizistan 5
LB - Libano 5
LY - Libia 5
SI - Slovenia 5
BB - Barbados 4
BG - Bulgaria 4
BH - Bahrain 4
KH - Cambogia 4
LK - Sri Lanka 4
MK - Macedonia 4
Totale 36.209
Salva come PNG Salva come JPEG
Città #
San Jose 2.799
Ashburn 2.018
Singapore 1.772
Rome 1.427
Hong Kong 1.285
Hefei 986
Dallas 694
Council Bluffs 690
Boardman 583
Columbus 501
London 464
Beijing 452
Lauterbourg 432
Shanghai 342
Ho Chi Minh City 209
Los Angeles 200
New York 161
Santa Clara 143
Hanoi 132
San Francisco 127
Pune 114
Phoenix 107
São Paulo 95
Milan 91
West Jordan 90
Munich 70
Amsterdam 69
Toronto 67
Washington 63
Chicago 58
Seattle 50
Brooklyn 46
Naples 46
Montreal 44
Mexico City 43
Brno 41
Denver 38
Buffalo 37
Warsaw 37
Sona 36
Tokyo 36
Las Vegas 35
Turku 35
Atlanta 34
Frankfurt am Main 30
Rio de Janeiro 30
Quito 29
Chennai 25
Guayaquil 24
Haiphong 24
Riyadh 23
Brasília 22
Florence 22
Helsinki 22
Kuala Lumpur 22
Melbourne 22
Boston 21
Jakarta 21
Da Nang 20
Manchester 19
Orem 19
Canberra 18
Charlotte 18
Hanover 18
Nuremberg 18
Paris 18
Bogotá 17
Bologna 17
Buenos Aires 17
Istanbul 17
New Delhi 17
Baghdad 16
Jeddah 16
Johannesburg 16
Philadelphia 16
San José 16
Turin 16
Jacksonville 15
Kingston 15
Porto Alegre 15
Stockholm 15
Sydney 15
Thái Bình 15
Cairo 14
Curitiba 14
Dhaka 14
Hải Dương 14
Central 13
Dublin 13
Ankara 12
Biên Hòa 12
Catania 12
Manila 12
Pittsburgh 12
Addis Ababa 11
Bangkok 11
Belo Horizonte 11
Brescia 11
Campinas 11
Glasgow 11
Totale 17.763
Salva come PNG Salva come JPEG
Nome #
PLASTIC IN PLACENTA: WHAT IS IT? WHAT TO DO? 451
112P Measuring time-toxicity and prognostic impact of hospital attendance in early phase cancer trials participants 349
18F-Choline PET/CT for early detection of prostate cancer recurrence after radical prostatectomy 341
1352P Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy 330
1338P TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC) 320
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 313
69P Dose-dependent detrimental effect of proton pump inhibitors (PPIs) on clinical outcomes from immune checkpoint inhibitors (ICI) in patients (pts) with solid tumors 266
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 258
1-year results of the subclavian access for tavi with the corevalve bioprosthesis in 132 consecutive patients 257
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 249
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 248
A new adjunct for emergency airway management:the Laryngeal Tube, preliminary data 246
Effect of hypothermia on human colonic smooth muscle contractility 243
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY 243
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 239
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 236
A biomechanical index for the evaluation of upper arm motor control in a subject affected by polyradiculoneuropathy 235
Purse-String Closure vs Conventional Direct Closure of Wounds after Stoma Reversal: A Prospective Randomized Controlled Study 234
Disclosing 3D Shape of Ossa Genitalia in Primates 226
602 Frequent Epigenetic Inactivation of KEAP1 Gene in Breast Cancer 225
P3.13C.09 First-Line Treatments for Advanced Pure Large Cell Neuroendocrine Tumors (LCNEC):Insights from a Global Clinico-Genomic Study 224
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 224
Diagnosis of labour: the II prospective clinical study 224
Postoperative Serum Procalcitonin to Predict Clinically Relevant Pancreatic Fistula after Pancreatoduodenectomy 224
Adipokines: The Missing Link between Alzheimer's Disease and Type 2 Diabetes? 221
3D Bioprinting of Human Skin and Squamous Cell Tumors (SCCs) as Advanced Models for Precision Medicine (BIOSQIN) 219
Gait Speed Is a Valid Indicator in the Assessment of Perioperative Risk in the Elderly Surgical Patient 218
EP24.13: Fetomaternal hemorrhage: a new hypothesis on the importance of fetal vasoconstriction – a case report 217
Chronotherapy and surgery for unresectable hepatic metastases from colorectal cancer 217
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single centre retrospective analysis 217
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 216
Does HE4 have a role in the recurrence of ovarian cancer? 215
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 213
Aligned electrospun poly-l-lactide fibers for tendon regeneration: a preliminary in vitro study 211
Assessment of liver function by the exhaled breath-print during chronic liver disease 210
APPLICATION OF RADIOFREQUENCY INTERSTITIAL TUMOR ABLATION(RITA) IN "NO CLAMP-NO SUTURE" LAPAROSCOPIC PARTIAL NEPHRECTOMY 209
Risultati preliminari dell’uso della risonanza magnetica nello studio dei disturbi dell’evacuazione 208
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 200
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 197
The Hendrich II model for assessing the risk of falls for hospitalized patients [Il modello Hendrich II per la valutazione del rischio di cadute per pazienti ospedalizzati] 196
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 196
Hepatic Artery Anomaly Does Not Impact Pancreatoduodenectomy Outcomes: A Matched Pair Analysis 195
Biomimetic Polyurethane Scaffolds Guiding the In Vitro Behavior of Cardiac Stem Cells 191
534 Determinants of 5-year survival in patients with advanced NSCLC with PD-L1 ≥50% treated with first line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry 187
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 181
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY. 172
OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab 161
EBUS-TBNA, EUS-FNA or EUS-B-FNA for mediastinal staging of lung cancer: A purpose of diagnostic algorithm 157
Cerebral Hemodynamics, Patent foramen ovale and White Matter Hyperintensities in patients Migraine with aura, young stroke patients and controls 155
35. Association of robot-assisted rehabilitation and non-invasive brain stimulation to improve upper limb function in chronic stroke patients 155
A polysaccharide foam-like scaffold obtained by crosslinking lactose-modified chitosan and oxidized hyaluronan 153
Abruptio placenta and TLRs 2-3-4 151
A case of synchronous hepatic and gastric malignancies: diagnostic problems and therapeutical strategies 149
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 148
706. DNA Vaccine Strategy Against Chronic B-Cell Lymphoma: Anti-Idiotypic CDR3 Vaccination 147
485 Impact of opioid signaling on the tumor microenvironment and clinical outcomes in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) 146
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 143
Alimentazione e gravidanza fisiologica 143
GH-resistance in different stages of chronic liver disease 142
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 138
A New Technique for Laparoscopic Stripping of Endometriomas: FloSeal Hemostatic Agent for Hemostasis of the Ovarian Wall 136
A Systematic Review of the Role of Lymphadenectomy in Pancreatic Cancer 135
A meta-synthesis of experiences of caregivers of people with COPD. 135
"NO CLAMP NO SUTURE'' LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR SMALL EXOPHYTIC RENAL TUMORS 134
Biological effects of cabozantinib on bone microenvironment 134
Amniotic membrane transplantation associated with conjunctival peritomy in the management of Mooren's ulcer. 132
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 132
35 DNA DOUBLE STRANDS BREAK REPAIR GENES EXPRESSION ANALYSIS REVEAL RAD51 AS A NEW POTENTIAL BIOMARKER IN BREAST CANCER. 131
Clinical outcomes and post-progression retreatment in patients with metastatic NSCLC who complete two years of treatment with immune checkpoint blockade 130
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 130
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 130
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 129
THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma 129
5-YEAR ONCOLOGIC OUTCOMES FOR ROBOT-ASSISTED AND LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR HIGH-RISK RENAL TUMORS 128
Assessment of renal damage following warm ischemia time during LPN: results of a prospective study 127
Chemokines and Inflammatory Mediators in Erosive Esophagitis (EE) Compared to Non-Erosive Reflux Disease (NERD) and Control Patients 127
66 ABERRANT GENES PROMOTER METHYLATION IN NEURAL-CREST DERIVED TUMOURS 127
Fetal head-symphysis distance: a simple and reliable ultrasound parameter for the intrapartum assessment of the fetal head descent 126
45 GENE EXPRESSION OF SOMATOSTATIN RECEPTOR SUBTYPES SSTR2a, SSTR3 AND SSTR5 IN PERIPHERAL BLOOD OF NEUROENDOCRINE LUNG CANCER AFFECTED PATIENTS 126
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 126
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 126
The ability of Lung High-Resolution Computed Tomography Severity Score to early identify COVID-19 patients who need respiratory support. A retrospective analysis of a monocentric Italian COVID-19 cohort 124
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 123
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 123
Baccalaureate nursing students’ attitudes towards old people 122
"NO CLAMPING-NO SUTURING" LAPAROSCOPIC PARTIAL NEPHRECTOMY (LPN). 122
How long is the latent phase of labour? 121
Continent ileocolonic urinary diversion (rome pouch) for gynecologic malignancies: techniqueand feasibility. 121
Amniotic membrane produces and releases nerve growth factor (NGF) and expresses NGF receptors 120
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 120
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 119
Integrated treatment of pancreatic head carcinoma 119
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 117
ALT levels are associated with metabolic parameters and age in a large real-life population. 117
T.07.3: CHARACTERISTICS AND OUTCOMES OF IMMUNOTHERAPYRELATED LIVER INJURY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA COMPARED TO PATIENTS WITH ADVANCED SOLID TUMOURS 116
Combined multimodality treatment of primary or recurrent locally advanced rectal cancer 111
Drug releasing hybrid scaffold: new avenue in cardiovascular tissue engineering 111
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 110
How the different systemic organ involvements are overlapped in patients with primary Sjogren syndrome: analysis using a mathematical model 110
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 109
Totale 17.964
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022697 0 0 0 6 57 8 6 3 24 32 13 548
2022/2023387 29 11 8 32 43 26 33 22 24 35 108 16
2023/20241.848 82 163 75 113 203 818 33 84 22 135 35 85
2024/202515.416 230 198 621 65 107 342 218 69 1.260 1.172 5.231 5.903
2025/202614.752 1.366 507 1.119 1.671 536 1.026 4.469 725 998 1.110 676 549
2026/20273.292 162 1.370 858 902 0 0 0 0 0 0 0 0
Totale 36.403